Biotechnology
100 Most Popular
Most Popular Under $25
Cara Therapeutics
$18.439876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$18.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.52 (-2.74%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell CARA and other stocks, options, ETFs, and crypto commission-free!
About
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. Read More The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Employees
55
Headquarters
Stamford, Connecticut
Founded
2004
Market Cap
749.95M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
789.13K
High Today
$18.98
Low Today
$18.31
Open Price
$18.75
Volume
212.14K
52 Week High
$24.30
52 Week Low
$12.19
Collections
Biotechnology
100 Most Popular
Most Popular Under $25
Health
Medical
Research And Development
Pharmaceutical
Technology
News
Yahoo FinanceMay 8
Cara Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
STAMFORD, Conn., May 08, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by selectively targeting peripheral kappa opioid receptors, today announced a Company presentation at the Bank of America Merrill Lynch 2019 Health Care Conference on Wednesday, May 15, 2019, at 5:00 p.m. PT (8:00 p.m. ET) in Las Vegas, NV. A live webcast of the presentation can be accessed under "Eve...
The Motley FoolMay 8
Cara Therapeutics Inc (CARA) Q1 2019 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q1 2019 Earnings Call , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon and welcome to Cara Therapeutics' First Quarter 2019 Financial Results Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara's request. I would like to turn the call over to the Cara team. Please ...
Price Paid on Robinhood
13% Higher
Right Now
52 Week Low
$12.19
Average Price Paid
$16.37
52 Week High
$24.30
Earnings
-$0.58
-$0.49
-$0.41
-$0.32
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 6, After Hours